[go: up one dir, main page]

Yuan et al., 2019 - Google Patents

Autofluorescence of NADH is a new biomarker for sorting and characterizing cancer stem cells in human glioma

Yuan et al., 2019

View HTML @Full View
Document ID
1728718801304562399
Author
Yuan Y
Yan Z
Miao J
Cai R
Zhang M
Wang Y
Wang L
Dang W
Wang D
Xiang D
Wang Y
Zhang P
Cui Y
Bian X
Ma Q
Publication year
Publication venue
Stem Cell Research & Therapy

External Links

Snippet

Background The existing cell surface markers used for sorting glioma stem cells (GSCs) have obvious limitations, such as vulnerability to the enzymatic digestion and time- consuming labeling procedure. Reduced nicotinamide adenine dinucleotide (NADH) as a …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes

Similar Documents

Publication Publication Date Title
Yuan et al. Autofluorescence of NADH is a new biomarker for sorting and characterizing cancer stem cells in human glioma
McCord et al. Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro
Sharif et al. Autophagic homeostasis is required for the pluripotency of cancer stem cells
Ehtesham et al. CXCR4 mediates the proliferation of glioblastoma progenitor cells
Choi et al. Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase
Touil et al. The PI3K/AKT signaling pathway controls the quiescence of the low-Rhodamine123-retention cell compartment enriched for melanoma stem cell activity
Khan et al. Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells
CN111492248B (en) Method for measuring therapeutic cell quality by real-time glutathione assay
US8614095B2 (en) Methods for identifying, purifying and enriching immature or stem cancer-initiating cells from tumors and use thereof
Vossmerbaeumer et al. Retinal pigment epithelial phenotype induced in human adipose tissue-derived mesenchymal stromal cells
Yang et al. Exosomes derived from glioma cells under hypoxia promote angiogenesis through up-regulated exosomal connexin 43
Pezzolo et al. Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells
Katsuta et al. CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells
Gao et al. Suppression of glioblastoma by a drug cocktail reprogramming tumor cells into neuronal like cells
Gianì et al. Thyrospheres from normal or malignant thyroid tissue have different biological, functional, and genetic features
Wang et al. Characterization of HIF‐1α/Glycolysis Hyperactive Cell Population via Small‐Molecule‐Based Imaging of Mitochondrial Transporter Activity
Lonardo et al. Studying pancreatic cancer stem cell characteristics for developing new treatment strategies
Miconi et al. Immunophenotypic characterization of human glioblastoma stem cells: correlation with clinical outcome
Cheng et al. Sustained hedgehog signaling in medulloblastoma tumoroids is attributed to stromal astrocytes and astrocyte-derived extracellular matrix
Xiao et al. Imaging of epidermal growth factor receptor on single breast cancer cells using surface-enhanced Raman spectroscopy
Alowaidi et al. Assessing stemness and proliferation properties of the newly established colon cancer ‘stem’cell line, CSC480 and novel approaches to identify dormant cancer cells
Gaelzer et al. Hypoxic and reoxygenated microenvironment: stemness and differentiation state in glioblastoma
Jain et al. Identification of cancer-associated fibroblasts in glioblastoma and defining their pro-tumoral effects
Kaseb et al. Cell division patterns and chromosomal segregation defects in oral cancer stem cells
Goldsmith et al. Targeting the platelet-derived growth factor-beta stimulatory circuitry to control retinoblastoma seeds